Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03277924
Title Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications

malignant fibrous histiocytoma

osteosarcoma

extraskeletal myxoid chondrosarcoma

malignant epithelioid hemangioendothelioma

leiomyosarcoma

alveolar soft part sarcoma

solitary fibrous tumor/hemangiopericytoma

chondrosarcoma

angiosarcoma

clear cell sarcoma

Therapies

Nivolumab + Sunitinib

Age Groups: adult | child | senior
Covered Countries ITA | ESP


No variant requirements are available.